Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
New GLP1-based multi-agonist therapies seem to be substantially more effective than older GLP1R agonists in reducing body weight but their safety requires ongoing scrutiny in trials assessing outcomes in individuals with obesity
20 g during weeks 3 and 4) demonstrated a maximum HR increase of 7.3 bpm 4 h post-dosing [22]
Nutrients, 16 (3), 509
Consider evaluating body composition using tools such as an InBody scale or DEXA scan to establish baseline values and monitor changes over time
Discontinuation rates were higher than in Phase 2 trials - 18.2% at the 12mg dose versus 4% with placebo
Patients with commercial drug coverage for Wegovy can reduce their monthly cost to $25 with the manufacturers Wegovy Savings Offer
US$ 26.82
US$ 27.03
US$ 23.79
